Table 1.
Summary of the effects on cFos expression of intraperitoneal injections of saline or CCK-8s
Control |
Deafferented |
|||||
---|---|---|---|---|---|---|
Saline | CCK-8s, 1 μg/kg | CCK-8s, 3 μg/kg | Saline | CCK-8s, 1 μg/kg | CCK-8s, 3 μg/kg | |
NTS | ||||||
Rx | 100 | 215.6± 70.21* | 262.9± 26.40* | 100 | 155.8± 29.78* | 315.0± 62.95* |
Lx | 100 | 213.3± 57.40 | 287.6± 55.78 | 100 | 141.1± 33.93 | 246.1± 41.70 |
cNTS | ||||||
Rx | 100 | 205.6± 37.49* | 318.1± 42.05* | 100 | 136.3± 41.70* | 308.5± 56.76* |
Lx | 100 | 244.8± 59.84 | 364.1± 63.48 | 100 | 155.8± 29.32 | 213.5± 22.55 |
Values are expressed as means ± SE. CCK-8s, cholecystokinin octapeptide; NTS, nucleus tractus solitarius; cNTS, nucleus tractus solitarius pars centralis; Rx, right side (afferent rhizotomy); Lx, left side (subdiaphragmatic vagotomy).
P = not significant vs. Lx.